These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 12297808)
21. High prevalence of antibiotic resistance in isolates from the middle meatus of children and adults with acute rhinosinusitis. Huang WH; Fang SY Am J Rhinol; 2004; 18(6):387-91. PubMed ID: 15706987 [TBL] [Abstract][Full Text] [Related]
27. Rhinosinusitis. An overview of current management measures in acute and chronic infection. Hadley JA Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):30-6. PubMed ID: 19667547 [TBL] [Abstract][Full Text] [Related]
30. Short treatment durations for acute bacterial rhinosinusitis: Five days of gemifloxacin versus 7 days of gemifloxacin. Ferguson BJ; Anon J; Poole MD; Hendrick K; Gilson M; Seltzer EG; Otolaryngol Head Neck Surg; 2002 Jul; 127(1):1-6. PubMed ID: 12161723 [TBL] [Abstract][Full Text] [Related]
31. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Lode H; Magyar P; Muir JF; Loos U; Kleutgens K; Clin Microbiol Infect; 2004 Jun; 10(6):512-20. PubMed ID: 15191378 [TBL] [Abstract][Full Text] [Related]
32. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007]. Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709 [TBL] [Abstract][Full Text] [Related]
33. [15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis]. Ovchinnikov AY; Edzhe MA; Miroshnichenko NA; Hon EM; Korostelev SA Vestn Otorinolaringol; 2015; 80(3):75-79. PubMed ID: 26331163 [TBL] [Abstract][Full Text] [Related]
34. Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study. Zhou B; Jiang X; Zhai L; Xiao S; Wang J; Xiao G; Ruan B; Liang C; Ye Q; Hu B; Wang H Acta Otolaryngol; 2010 Sep; 130(9):1058-64. PubMed ID: 20235900 [TBL] [Abstract][Full Text] [Related]
35. Treatment of rhinosinusitis in the outpatient setting. Poole MD; Portugal LG Am J Med; 2005 Jul; 118 Suppl 7A():45S-50S. PubMed ID: 15993677 [TBL] [Abstract][Full Text] [Related]
36. Beginning antibiotics for acute rhinosinusitis and choosing the right treatment. Wald ER Clin Rev Allergy Immunol; 2006 Jun; 30(3):143-52. PubMed ID: 16785586 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia. Topkis S; Swarz H; Breisch SA; Maroli AN Clin Ther; 1997; 19(5):975-88. PubMed ID: 9385485 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness, safety and tolerability of gatifloxacin, a new 8-methoxyfluoroquinolone, in the treatment of outpatients with community-acquired pneumonia: a Brazilian study. Franca SA; Carvalho CR Braz J Infect Dis; 2002 Aug; 6(4):157-63. PubMed ID: 12204182 [TBL] [Abstract][Full Text] [Related]
39. A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. Finch RG Int J Antimicrob Agents; 1999 Jun; 12(1):5-17. PubMed ID: 10389642 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study. Fogarty CM; Patel TC; Dunbar LM; Leroy BP BMC Infect Dis; 2005 May; 5():43. PubMed ID: 15927060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]